Spine Biologics Market Report

RA01652

Spine Biologics Market, by Product (Bone Graft, Bone Graft Substitute, Platelet Rich Plasma, BMAC), Surgery (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA01652

Pages: NA

Jan 2021

OFFERINGS OF THE REPORT:

The report offers comprehensive analysis of the global spine biologics market by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market.

The report also sheds light on present scenario and upcoming trends and developments that are contributing in the growth of the market. In addition, key market boomers and opportunities driving the market growth are provided in the report. Besides, restraints and challenges that hold power to obstruct the market growth are also profiled in the report. The report also offers Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the market.

Based on the key forces molding the market, the report offers future perspective and growth outlook of the global market. The report offers market size and forecast by keenly evaluating every segment of the global spine biologics market. Regional market breakdown of these segments is also offered in the report. The report divides the global spine biologics market into four main regions including Europe, North America, Asia-Pacific, and LAMEA. Furthermore, these regions are sub-divided to profile detailed panorama of the spine biologics market across major countries in specific regions. Moreover, the report reveals some of the recent developments, trends, and forthcoming opportunities in every region.

HIGHLIGHTS OF THE MARKET

The report offers market size and forecast for the period from 2019 to 2027
This report highlights trends, innovations, and new developments along with a detailed quantitative analysis of the spine biologics market during the period of forecast
The prevailing and upcoming opportunities along with the tactical assessment of the global spine biologics market growth is provided
The market size and estimations are based on a comprehensive analysis of market drivers and restraints and key innovations in the spine biologics market
Information on leading market players, Porter’s Five Analysis, and top winning business strategies is offered
The development plans and initiatives undertaken by the top market players are highlighted to understand the competitive landscape of the market

KEY MARKET SEGMENTS

The report segments the global market into product ,surgery

Product: Bone Graft, Bone Graft Substitute, Platelet Rich Plasma, BMAC

Surgery: Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion

Region:

The global spine biologics market is divided into North America, Europe, Asia Pacific, and LAMEA.

The above-mentioned regions are further dived in countries as follows:

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA

LEADING PLAYERS OF THE MARKET

The most influential companies are mentioned in the report which include Zimmer Holding Inc., Wright Medical Technology Inc., Depuy Synthes Companies ,

The report outlines the business overview including financial performance, latest strategic moves & developments, product portfolio, and SWOT analysis of the leading players of the spine biologics market.

1. Medtronic Inc.

2. Depuy Synthes Companies

3. Zimmer Holding Inc.

4. Nuvasive Inc.

5. Stryker Corporation

6. Orthofix International N.V

7. K2M Inc.

8. Exactech Inc.

9. Wright Medical Technology Inc.

10.

RESEARCH METHODOLOGY

The report is formulated by in-house market analysts by deeply scrutinizing the market scenario. The market predictions stated in the report have been derived using proven research methodologies and analytical tools & models. Use of such advanced and effective tools, helps market analysts in scrutinizing, filtering, and offering highly accurate data and predictions. The report delivers an extensive research and analysis backed with a variety of factual data, which mainly include interviews with industry players, trustworthy and renowned sources of statistics, and regional intelligence. The insights provided in the report can help investors in understanding investment suitability and market players to grab opportunities for investments, partnerships, and developments in the global market.

The research report is formed by collating different statistics and information concerning the spine biologics market. For instance, around 18 hours of interviews and deliberations have been performed with a group of stakeholders and investors, including upstream and downstream members. Primary research is the main part of the research efforts; however, it is reasonably supported by all-encompassing secondary research. About 5,900 product type literatures, market publications, company annual reports, and other such relevant documents of key market players have been studied, for better understanding of market penetration. Furthermore, trustworthy industry newsletters, medical journals, trade associations’ publications, and government websites have also been evaluated for extracting vital industry insights.

1. RESEARCH METHODOLOGY
- 1.1. Desk Research
- 1.2. Real time insights and validation
- 1.3. Forecast model
- 1.4. Assumptions and forecast parameters
- 1.5. Market size estimation
  - 1.5.1. Top-down approach
  - 1.5.2. Bottom-up approach
2. REPORT SCOPE
- 2.1. Market definition
- 2.2. Key objectives of the study
- 2.3. Report overview
- 2.4. Market segmentation
- 2.5. Overview of the impact of COVID-19 on Global Spine Biologics Market
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
- 4.1. Introduction
- 4.2. Growth impact forces
  - 4.2.1. Drivers
  - 4.2.2. Restraints
  - 4.2.3. Opportunities
- 4.3. Market value chain analysis
  - 4.3.1. List of raw material suppliers
  - 4.3.2. List of manufacturers
  - 4.3.3. List of distributors
- 4.4. Innovation & sustainability matrices
  - 4.4.1. Technology matrix
  - 4.4.2. Regulatory matrix
- 4.5. Porter’s five forces analysis
  - 4.5.1. Bargaining power of suppliers
  - 4.5.2. Bargaining power of consumers
  - 4.5.3. Threat of substitutes
  - 4.5.4. Threat of new entrants
  - 4.5.5. Competitive rivalry intensity
- 4.6. PESTLE analysis
  - 4.6.1. Political
  - 4.6.2. Economical
  - 4.6.3. Social
  - 4.6.4. Technological
  - 4.6.5. Environmental
- 4.7. Impact of COVID-19 on Spine Biologics Market
  - 4.7.1. Pre-covid market scenario
  - 4.7.2. Post-covid market scenario
5. Spine Biologics Market, By Product
- 5.1. Overview
- 5.2 Bone Graft
  - 5.2.1 Definition, key trends, growth factors, and opportunities
  - 5.2.2 Market size analysis, by region, 2020-2027
  - 5.2.3 Market share analysis, by country, 2020-2027
- 5.3 Bone Graft Substitute
  - 5.3.1 Definition, key trends, growth factors, and opportunities
  - 5.3.2 Market size analysis, by region, 2020-2027
  - 5.3.3 Market share analysis, by country, 2020-2027
- 5.4 Platelet Rich Plasma
  - 5.4.1 Definition, key trends, growth factors, and opportunities
  - 5.4.2 Market size analysis, by region, 2020-2027
  - 5.4.3 Market share analysis, by country, 2020-2027
- 5.5 BMAC
  - 5.5.1 Definition, key trends, growth factors, and opportunities
  - 5.5.2 Market size analysis, by region, 2020-2027
  - 5.5.3 Market share analysis, by country, 2020-2027
- 5.6 Research Dive Exclusive Insights
  - 5.6.1 Market attractiveness
  - 5.6.2 Competition heatmap
6. Spine Biologics Market, By Testing Type
- 6.1. Overview
- 6.2 Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion
  - 6.2.1 Definition, key trends, growth factors, and opportunities
  - 6.2.2 Market size analysis, by region, 2020-2027
  - 6.2.3 Market share analysis, by country, 2020-2027
- 6.3 Research Dive Exclusive Insights
  - 6.3.1 Market attractiveness
  - 6.3.2 Competition heatmap
7. Spine Biologics Market, By Region
- 7.1 North America
  - 7.1.1 U.S
    - 7.1.1.1 Market size analysis, By Product, 2020-2027
    - 7.1.1.2 Market size analysis, By Testing Type, 2020-2027
  - 7.1.2 Canada
    - 7.1.2.1 Market size analysis, By Product, 2020-2027
    - 7.1.2.2 Market size analysis, By Testing Type, 2020-2027
  - 7.1.3 Mexico
    - 7.1.3.1 Market size analysis, By Product, 2020-2027
    - 7.1.3.2 Market size analysis, By Testing Type, 2020-2027
  - 7.1.4 Research Dive Exclusive Insights
    - 7.1.4.1 Market attractiveness
    - 7.1.4.2 Competition heatmap
- 7.2 Europe
  - 7.2.1 Germany
    - 7.2.1.1 Market size analysis, By Product, 2020-2027
    - 7.2.1.2 Market size analysis, By Testing Type, 2020-2027
  - 7.2.2 UK
    - 7.2.2.1 Market size analysis, By Product, 2020-2027
    - 7.2.2.2 Market size analysis, By Testing Type, 2020-2027
  - 7.2.3 France
    - 7.2.3.1 Market size analysis, By Product, 2020-2027
    - 7.2.3.2 Market size analysis, By Testing Type, 2020-2027
  - 7.2.4 Spain
    - 7.2.4.1 Market size analysis, By Product, 2020-2027
    - 7.2.4.2 Market size analysis, By Testing Type, 2020-2027
  - 7.2.5 Italy
    - 7.2.5.1 Market size analysis, By Product, 2020-2027
    - 7.2.5.2 Market size analysis, By Testing Type, 2020-2027
  - 7.2.6 Rest of Europe
    - 7.2.6.1 Market size analysis, By Product, 2020-2027
    - 7.2.6.2 Market size analysis, By Testing Type, 2020-2027
  - 7.2.7 Research Dive Exclusive Insights
    - 7.2.7.1 Market attractiveness
    - 7.2.7.2 Competition heatmap
- 7.3 Asia-Pacific
  - 7.3.1 China
    - 7.3.1.1 Market size analysis, By Product, 2020-2027
    - 7.3.1.2 Market size analysis, By Testing Type, 2020-2027
  - 7.3.2 Japan
    - 7.3.2.1 Market size analysis, By Product, 2020-2027
    - 7.3.2.2 Market size analysis, By Testing Type, 2020-2027
  - 7.3.3 India
    - 7.3.3.1 Market size analysis, By Product, 2020-2027
    - 7.3.3.2 Market size analysis, By Testing Type, 2020-2027
  - 7.3.4 Australia
    - 7.3.4.1 Market size analysis, By Product, 2020-2027
    - 7.3.4.2 Market size analysis, By Testing Type, 2020-2027
  - 7.3.5 South Korea
    - 7.3.5.1 Market size analysis, By Product, 2020-2027
    - 7.3.5.2 Market size analysis, By Testing Type, 2020-2027
  - 7.3.6 Rest of Asia-Pacific
    - 7.3.6.1 Market size analysis, By Product, 2020-2027
    - 7.3.6.2 Market size analysis, By Testing Type, 2020-2027
  - 7.3.7 Research Dive Exclusive Insights
    - 7.3.7.1 Market attractiveness
    - 7.3.7.2 Competition heatmap
- 7.4 LAMEA
  - 7.4.1 Brazil
    - 7.4.1.1 Market size analysis, By Product, 2020-2027
    - 7.4.1.2 Market size analysis, By Testing Type, 2020-2027
  - 7.4.2 Saudi Arabia
    - 7.4.2.1 Market size analysis, By Product, 2020-2027
    - 7.4.2.2 Market size analysis, By Testing Type, 2020-2027
  - 7.4.3 UAE
    - 7.4.3.1 Market size analysis, By Product, 2020-2027
    - 7.4.3.2 Market size analysis, By Testing Type, 2020-2027
  - 7.4.4 South Africa
    - 7.4.4.1 Market size analysis, By Product, 2020-2027
    - 7.4.4.2 Market size analysis, By Testing Type, 2020-2027
  - 7.4.5 Rest of LAMEA
    - 7.4.5.1 Market size analysis, By Product, 2020-2027
    - 7.4.5.2 Market size analysis, By Testing Type, 2020-2027
  - 7.4.6 Research Dive Exclusive Insights
    - 7.4.6.1 Market attractiveness
    - 7.4.6.2 Competition heatmap
8. Competitive Landscape
- 8.1 Top winning strategies, 2020-2027
  - 8.1.1 By strategy
  - 8.1.2 By year
- 8.2 Strategic overview
- 8.3 Market share analysis, 2020-2027
9. Company Profiles
- 9.1 Medtronic Inc.
  - 9.1.1 Overview
  - 9.1.2 Business segments
  - 9.1.3 Product portfolio
  - 9.1.4 Financial performance
  - 9.1.5 Recent developments
  - 9.1.6 SWOT analysis
- 9.2 Depuy Synthes Companies
  - 9.2.1 Overview
  - 9.2.2 Business segments
  - 9.2.3 Product portfolio
  - 9.2.4 Financial performance
  - 9.2.5 Recent developments
  - 9.2.6 SWOT analysis
- 9.3 Zimmer Holding Inc.
  - 9.3.1 Overview
  - 9.3.2 Business segments
  - 9.3.3 Product portfolio
  - 9.3.4 Financial performance
  - 9.3.5 Recent developments
  - 9.3.6 SWOT analysis
- 9.4 Nuvasive Inc.
  - 9.4.1 Overview
  - 9.4.2 Business segments
  - 9.4.3 Product portfolio
  - 9.4.4 Financial performance
  - 9.4.5 Recent developments
  - 9.4.6 SWOT analysis
- 9.5 Stryker Corporation
  - 9.5.1 Overview
  - 9.5.2 Business segments
  - 9.5.3 Product portfolio
  - 9.5.4 Financial performance
  - 9.5.5 Recent developments
  - 9.5.6 SWOT analysis
- 9.6 Orthofix International N.V
  - 9.6.1 Overview
  - 9.6.2 Business segments
  - 9.6.3 Product portfolio
  - 9.6.4 Financial performance
  - 9.6.5 Recent developments
  - 9.6.6 SWOT analysis
- 9.7 K2M Inc.
  - 9.7.1 Overview
  - 9.7.2 Business segments
  - 9.7.3 Product portfolio
  - 9.7.4 Financial performance
  - 9.7.5 Recent developments
  - 9.7.6 SWOT analysis
- 9.8 Exactech Inc.
  - 9.8.1 Overview
  - 9.8.2 Business segments
  - 9.8.3 Product portfolio
  - 9.8.4 Financial performance
  - 9.8.5 Recent developments
  - 9.8.6 SWOT analysis
- 9.9 Wright Medical Technology Inc.
  - 9.9.1 Overview
  - 9.9.2 Business segments
  - 9.9.3 Product portfolio
  - 9.9.4 Financial performance
  - 9.9.5 Recent developments
  - 9.9.6 SWOT analysis
- 9.10
  - 9.10.1 Overview
  - 9.10.2 Business segments
  - 9.10.3 Product portfolio
  - 9.10.4 Financial performance
  - 9.10.5 Recent developments
  - 9.10.6 SWOT analysis

Research Methodology

Purchase Options

Individual License $4290 Corporate License $4920

Personalize this research

Triangulate with your own data
Request your format and definition
Get a deeper dive on a specific application, geography, customer or competitor

10% Off on Customization

Speak To The Analyst
Or Schedule A Call

+ 1-888-961-4454 Toll - Free
support@researchdive.com

Spine Biologics Market Report

Spine Biologics Market, by Product (Bone Graft, Bone Graft Substitute, Platelet Rich Plasma, BMAC), Surgery (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion): Global Opportunity Analysis and Industry Forecast, 2020-2027

1. RESEARCH METHODOLOGY

1.1. Desk Research

1.2. Real time insights and validation

1.3. Forecast model

1.4. Assumptions and forecast parameters

1.5. Market size estimation

1.5.1. Top-down approach

1.5.2. Bottom-up approach

2. REPORT SCOPE

2.1. Market definition

2.2. Key objectives of the study

2.3. Report overview

2.4. Market segmentation

2.5. Overview of the impact of COVID-19 on Global Spine Biologics Market

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

4.1. Introduction

4.2. Growth impact forces

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Market value chain analysis

4.3.1. List of raw material suppliers

4.3.2. List of manufacturers

4.3.3. List of distributors

4.4. Innovation & sustainability matrices

4.4.1. Technology matrix

4.4.2. Regulatory matrix

4.5. Porter’s five forces analysis

4.5.1. Bargaining power of suppliers

4.5.2. Bargaining power of consumers

4.5.3. Threat of substitutes

4.5.4. Threat of new entrants

4.5.5. Competitive rivalry intensity

4.6. PESTLE analysis

4.6.1. Political

4.6.2. Economical

4.6.3. Social

4.6.4. Technological

4.6.5. Environmental

4.7. Impact of COVID-19 on Spine Biologics Market

4.7.1. Pre-covid market scenario

4.7.2. Post-covid market scenario

5. Spine Biologics Market, By Product

5.1. Overview

5.2 Bone Graft

5.2.1 Definition, key trends, growth factors, and opportunities

5.2.2 Market size analysis, by region, 2020-2027

5.2.3 Market share analysis, by country, 2020-2027

5.3 Bone Graft Substitute

5.3.1 Definition, key trends, growth factors, and opportunities

5.3.2 Market size analysis, by region, 2020-2027

5.3.3 Market share analysis, by country, 2020-2027

5.4 Platelet Rich Plasma

5.4.1 Definition, key trends, growth factors, and opportunities

5.4.2 Market size analysis, by region, 2020-2027

5.4.3 Market share analysis, by country, 2020-2027

5.5 BMAC

5.5.1 Definition, key trends, growth factors, and opportunities

5.5.2 Market size analysis, by region, 2020-2027

5.5.3 Market share analysis, by country, 2020-2027

5.6 Research Dive Exclusive Insights

5.6.1 Market attractiveness

5.6.2 Competition heatmap

6. Spine Biologics Market, By Testing Type

6.1. Overview

6.2 Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion

6.2.1 Definition, key trends, growth factors, and opportunities

6.2.2 Market size analysis, by region, 2020-2027

6.2.3 Market share analysis, by country, 2020-2027

6.3 Research Dive Exclusive Insights

6.3.1 Market attractiveness

6.3.2 Competition heatmap

7. Spine Biologics Market, By Region

7.1 North America

7.1.1 U.S

7.1.1.1 Market size analysis, By Product, 2020-2027

7.1.1.2 Market size analysis, By Testing Type, 2020-2027